Free Trial

Snail (SNAL) Competitors

Snail logo
$0.58 -0.01 (-1.93%)
Closing price 04:00 PM Eastern
Extended Trading
$0.57 -0.01 (-1.49%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SNAL vs. AVNS, ARBE, HCAT, PODC, and AEYE

Should you be buying Snail stock or one of its competitors? The main competitors of Snail include Avanos Medical (AVNS), Arbe Robotics (ARBE), Health Catalyst (HCAT), PodcastOne (PODC), and Audioeye (AEYE).

How does Snail compare to Avanos Medical?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Avanos Medical has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Snail has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avanos Medical$701.20M1.64-$72.90M-$1.58N/A
Snail$81.23M0.27-$27.24M-$0.74N/A

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 0.4% of Snail shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 68.3% of Snail shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Avanos Medical had 3 more articles in the media than Snail. MarketBeat recorded 6 mentions for Avanos Medical and 3 mentions for Snail. Snail's average media sentiment score of 0.55 beat Avanos Medical's score of 0.44 indicating that Snail is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avanos Medical
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Snail
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Avanos Medical has a net margin of -10.40% compared to Snail's net margin of -17.79%. Avanos Medical's return on equity of 5.47% beat Snail's return on equity.

Company Net Margins Return on Equity Return on Assets
Avanos Medical-10.40% 5.47% 4.05%
Snail -17.79%-12.69%-1.94%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avanos Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Snail
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Avanos Medical beats Snail on 8 of the 15 factors compared between the two stocks.

How does Snail compare to Arbe Robotics?

Arbe Robotics (NASDAQ:ARBE) and Snail (NASDAQ:SNAL) are both small-cap computer software companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

Arbe Robotics has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Snail has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.

Snail has higher revenue and earnings than Arbe Robotics. Arbe Robotics is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arbe Robotics$1.03M98.12-$46.42M-$0.41N/A
Snail$81.23M0.27-$27.24M-$0.74N/A

In the previous week, Snail had 3 more articles in the media than Arbe Robotics. MarketBeat recorded 3 mentions for Snail and 0 mentions for Arbe Robotics. Arbe Robotics' average media sentiment score of 1.25 beat Snail's score of 0.55 indicating that Arbe Robotics is being referred to more favorably in the media.

Company Overall Sentiment
Arbe Robotics Positive
Snail Positive

Snail has a net margin of -17.79% compared to Arbe Robotics' net margin of -4,402.73%. Snail's return on equity of -12.69% beat Arbe Robotics' return on equity.

Company Net Margins Return on Equity Return on Assets
Arbe Robotics-4,402.73% -82.00% -57.89%
Snail -17.79%-12.69%-1.94%

33.4% of Arbe Robotics shares are held by institutional investors. Comparatively, 0.4% of Snail shares are held by institutional investors. 68.3% of Snail shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Arbe Robotics presently has a consensus target price of $2.25, indicating a potential upside of 173.06%. Given Arbe Robotics' stronger consensus rating and higher possible upside, equities analysts clearly believe Arbe Robotics is more favorable than Snail.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbe Robotics
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Snail
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Snail beats Arbe Robotics on 9 of the 16 factors compared between the two stocks.

How does Snail compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Snail (NASDAQ:SNAL) are both small-cap computer software companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 0.4% of Snail shares are held by institutional investors. 2.6% of Health Catalyst shares are held by company insiders. Comparatively, 68.3% of Snail shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Health Catalyst currently has a consensus price target of $2.80, indicating a potential upside of 74.72%. Given Health Catalyst's stronger consensus rating and higher possible upside, equities research analysts plainly believe Health Catalyst is more favorable than Snail.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.23
Snail
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Snail has lower revenue, but higher earnings than Health Catalyst. Snail is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$311.14M0.38-$177.97M-$2.54N/A
Snail$81.23M0.27-$27.24M-$0.74N/A

In the previous week, Health Catalyst had 2 more articles in the media than Snail. MarketBeat recorded 5 mentions for Health Catalyst and 3 mentions for Snail. Snail's average media sentiment score of 0.55 beat Health Catalyst's score of 0.22 indicating that Snail is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health Catalyst
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Snail
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Snail has a net margin of -17.79% compared to Health Catalyst's net margin of -57.20%. Health Catalyst's return on equity of -4.30% beat Snail's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-57.20% -4.30% -2.16%
Snail -17.79%-12.69%-1.94%

Health Catalyst has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, Snail has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Summary

Health Catalyst beats Snail on 10 of the 16 factors compared between the two stocks.

How does Snail compare to PodcastOne?

Snail (NASDAQ:SNAL) and PodcastOne (NASDAQ:PODC) are both small-cap computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

PodcastOne has a net margin of -6.22% compared to Snail's net margin of -17.79%. Snail's return on equity of -12.69% beat PodcastOne's return on equity.

Company Net Margins Return on Equity Return on Assets
Snail-17.79% -12.69% -1.94%
PodcastOne -6.22%-24.78%-16.46%

0.4% of Snail shares are owned by institutional investors. Comparatively, 2.9% of PodcastOne shares are owned by institutional investors. 68.3% of Snail shares are owned by insiders. Comparatively, 79.4% of PodcastOne shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PodcastOne has lower revenue, but higher earnings than Snail. PodcastOne is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Snail$81.23M0.27-$27.24M-$0.74N/A
PodcastOne$60.10M1.57-$6.46M-$0.15N/A

In the previous week, Snail and Snail both had 3 articles in the media. Snail's average media sentiment score of 0.55 beat PodcastOne's score of 0.38 indicating that Snail is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Snail
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PodcastOne
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Snail
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
PodcastOne
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Snail has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, PodcastOne has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500.

Summary

Snail and PodcastOne tied by winning 7 of the 14 factors compared between the two stocks.

How does Snail compare to Audioeye?

Snail (NASDAQ:SNAL) and Audioeye (NASDAQ:AEYE) are both small-cap computer software companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

Snail has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Audioeye has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Audioeye has lower revenue, but higher earnings than Snail. Audioeye is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Snail$81.23M0.27-$27.24M-$0.74N/A
Audioeye$40.31M2.34-$3.08M-$0.24N/A

In the previous week, Audioeye had 2 more articles in the media than Snail. MarketBeat recorded 5 mentions for Audioeye and 3 mentions for Snail. Snail's average media sentiment score of 0.55 beat Audioeye's score of 0.24 indicating that Snail is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Snail
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Audioeye
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Audioeye has a consensus price target of $14.63, indicating a potential upside of 93.97%. Given Audioeye's stronger consensus rating and higher possible upside, analysts plainly believe Audioeye is more favorable than Snail.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Snail
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Audioeye
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Audioeye has a net margin of -7.63% compared to Snail's net margin of -17.79%. Audioeye's return on equity of 56.26% beat Snail's return on equity.

Company Net Margins Return on Equity Return on Assets
Snail-17.79% -12.69% -1.94%
Audioeye -7.63%56.26%11.17%

0.4% of Snail shares are owned by institutional investors. Comparatively, 51.1% of Audioeye shares are owned by institutional investors. 68.3% of Snail shares are owned by company insiders. Comparatively, 28.8% of Audioeye shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Audioeye beats Snail on 11 of the 16 factors compared between the two stocks.

Get Snail News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNAL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNAL vs. The Competition

MetricSnailGAMING IndustryDiscretionary SectorNASDAQ Exchange
Market Cap$21.86M$6.22B$7.12B$11.87B
Dividend YieldN/A2.06%2.87%5.21%
P/E Ratio-0.7815.4616.9528.47
Price / Sales0.273.013.7460.92
Price / CashN/A20.2313.0036.52
Price / Book-1.006.743.566.67
Net Income-$27.24M-$32.47M$267.38M$332.53M
7 Day Performance-9.57%-0.76%-0.86%2.01%
1 Month Performance13.67%11.30%5.81%9.19%
1 Year Performance-45.42%-8.66%10.62%39.59%

Snail Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNAL
Snail
1.3427 of 5 stars
$0.58
-1.9%
N/AN/A$21.86M$81.23MN/A60
AVNS
Avanos Medical
1.0918 of 5 stars
$24.64
+0.0%
N/AN/A$1.15B$701.20MN/A2,287
ARBE
Arbe Robotics
1.865 of 5 stars
$0.77
+0.2%
$2.25
+191.8%
N/A$95.67M$1.03MN/A120
HCAT
Health Catalyst
2.7055 of 5 stars
$1.26
-6.2%
$2.80
+122.4%
N/A$93.38M$311.14MN/A1,200
PODC
PodcastOne
1.9357 of 5 stars
$3.34
+0.6%
N/AN/A$91.84M$60.10MN/AN/A

Related Companies and Tools


This page (NASDAQ:SNAL) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners